HIQA Rapid Health Technology Assessment of RSV Immunisation for Infants and Older Adults in Ireland (hiqa.ie)

• HIQA published rapid HTA on RSV immunisation for Ireland on 13 August 2024.
• Evaluates nirsevimab for infants and vaccines for older adults (60+).
• Informs policy for 2025-2026 RSV immunisation season.

"HIQA published a rapid health technology assessment (HTA) on RSV immunisation in Ireland on 13 August 2024. The HTA evaluates nirsevimab for infants and RSVpreF/RSVPreF3 for older adults to inform policy for the 2025-2026 season, following a pilot programme for 2024-2025 announced by the Minister for Health."